Clinical Trial Update: Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia [NA]

View source ↗

Summary

Clinical trial evaluating the combination of venetoclax with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) for hyperleukocytic acute promyelocytic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• All-trans retinoic acid (ATRA) (all-trans retinoic acid)
• Arsenic Trioxide (arsenic trioxide)
• Venetoclax (venetoclax)

Snippet

Sponsor: Anhui Medical University | Conditions: Acute Promyelocytic Leukemia (APL) | NA | Status: ACTIVE_NOT_RECRUITING